-
discovery and development through in vitro modelling of in-patient conditions in order to address antibiotic resistance, a problem of global importance. To reach this goal, AntiResist has assembled a panel of
-
discovery and development through in vitro modelling of in-patient conditions in order to address antibiotic resistance, a problem of global importance. To reach this goal, AntiResist has assembled a panel of
-
, microbiology, infection biology and immunology, cell and developmental biology, neurobiology, genetics as well as computational and systems biology. With over 30 groups, about 150 PhD students and over 500
-
a Swiss-wide research consortium funded by the Swiss National Science Foundation (SNSF). AntiResist is transforming antibiotic discovery and development through in vitro modelling of in-patient
-
, microbiology, infection biology and immunology, cell and developmental biology, neurobiology, genetics as well as computational and systems biology. With over 30 groups, about 150 PhD students and over 500
-
, physics of living systems, structural biology, microbiology, infection biology and immunology, cell and developmental biology, neurobiology, genetics as well as computational and systems biology. With over